HYDROXYZINE PAMOATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydroxyzine Pamoate, and what generic alternatives are available?
Hydroxyzine Pamoate is a drug marketed by Barr, Barr Labs, Beximco Pharms Usa, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, and Watson Labs. and is included in thirty-four NDAs.
The generic ingredient in HYDROXYZINE PAMOATE is hydroxyzine pamoate. There is one drug master file entry for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydroxyzine Pamoate
A generic version of HYDROXYZINE PAMOATE was approved as hydroxyzine pamoate by SANDOZ on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HYDROXYZINE PAMOATE?
- What are the global sales for HYDROXYZINE PAMOATE?
- What is Average Wholesale Price for HYDROXYZINE PAMOATE?
Summary for HYDROXYZINE PAMOATE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 34 |
| Finished Product Suppliers / Packagers: | 28 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,335 |
| Drug Prices: | Drug price information for HYDROXYZINE PAMOATE |
| Drug Sales Revenues: | Drug sales revenues for HYDROXYZINE PAMOATE |
| What excipients (inactive ingredients) are in HYDROXYZINE PAMOATE? | HYDROXYZINE PAMOATE excipients list |
| DailyMed Link: | HYDROXYZINE PAMOATE at DailyMed |
Recent Clinical Trials for HYDROXYZINE PAMOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shalvata Mental Health Center | N/A |
Pharmacology for HYDROXYZINE PAMOATE
| Drug Class | Antihistamine |
| Mechanism of Action | Histamine Receptor Antagonists |
